 use total artificial heart Symbion ventricular assist device bridge transplantation proliferation transplantation programs similar increase availability organ donors Between orthotopic heart transplantations Loyola University Medical Center period patients donor organ mortality total artificial heart TAH ventricular assist device VAD bridge transplantation patients underwent transplantation patients TAH patients VAD bridge underlying heart conditions ischemic cardiomyopathy patients cardiomyopathy patients giant cell myocarditis patient allograft failure patient average duration mechanical support days range days patients underwent transplantation patient days acute rejection transplanted heart patient days cerebral vascular event Fifteen patients long-term survivors Nine patients reoperation mechanical device place activated clotting time seconds heparin Dipyridamole TAH VAD excellent mechanical bridges transplantation